Estrogen is a vital stimulant of breast cancer cells that expresses estrogen receptors (ER, especially ERα); therefore, antiestrogens and aromatase inhibitors have become pivotal as a therapeutic modality of ER-positive breast cancer patients [2,3]. Here, ESR1 is linked to breast cancer.